Aanjaneya Lifecare has bagged a new order from Wockhardt for their brand Recodex and four other clients. The company has confirmed order book of Rs 60 crore from new clients such as Wockhardt, Cipla, Remedica, Tanzania Pharmaceutical, Activo SA and Pharmed Europe to be executed within next two months.
The company has seen impressive growth in its formulations business in pain management, cough cold, herbal and anti-Malarial segments. It is estimated by the company that these new orders from new clients will have a positive impact by over 20% in sales and 5% on EBIDTA margins this financial year.
The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (API). APIs, also known as bulk drugs‘ or bulk actives‘ are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients. The company specializes in anti-malaria drugs and Finished Dosage Forms (FDFs) for various therapeutic segments.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.00 |
| Dr. Reddys Lab | 1289.80 |
| Cipla | 1310.05 |
| Zydus Lifesciences | 954.55 |
| Lupin | 2276.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: